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Although genome-wide hypomethylation is a hall-
mark ofmany cancers, roles for active DNAdemethy-
lation during tumorigenesis are unknown. Here, loss
of the APC tumor suppressor gene causes upregula-
tion of a DNA demethylase system and the concom-
itant hypomethylation of key intestinal cell fating
genes. Notably, this hypomethylation maintained
zebrafish intestinal cells in an undifferentiated state
that was released upon knockdown of deme-
thylase components. Mechanistically, the demethy-
lase genes are directly activated by Pou5f1 and
Cebpb and are indirectly repressed by retinoic acid,
which antagonizes Pou5f1 and Cebpb. Apc mutants
lack retinoic acid as a result of the transcriptional
repression of retinol dehydrogenase l1 via a complex
that includes Lef1, Groucho2, Ctbp1, Lsd1, and
Corest. Our findings imply a model wherein APC
controls intestinal cell fating through a switch in
DNA methylation dynamics. Wild-type APC and reti-
noic acid downregulate demethylase components,
thereby promoting DNA methylation of key genes
and helping progenitors commit to differentiation.
INTRODUCTION
Loss of the adenomatous polyposis coli (APC) tumor suppressor
gene is the key initiating step in a model of genetic and epige-
netic events that lead to colorectal cancer. Germline mutations
in APC result in the development of familial adenomatous poly-
posis (FAP), a syndrome characterized by early onset of colon
cancer (Bienz and Clevers, 2000). In addition, APC is mutated930 Cell 142, 930–942, September 17, 2010 ª2010 Elsevier Inc.in more than 85% of sporadic colon tumors (Sparks et al.,
1998). The primary function of APC is attributed to its role in
negatively regulating WNT signaling. Mechanistically, APC
controls WNT signaling by targeting the transcriptional coactiva-
tor b-catenin for proteasomal degradation, thereby preventing
its association with the nuclear transcription factor TCF/LEF
(Bienz and Clevers, 2000). The mechanisms underlying APC
suppression of tumor formation remain an area of active investi-
gation, with several lines of evidence suggesting that APC serves
roles in addition to regulating WNT signaling. Recent reports
suggest that APC controls retinoic acid (RA) production which
in part relies upon the transcriptional regulator CtBP1 (Phelps
et al., 2009b; Nadauld et al., 2006).
Among the early events proposed to contribute to the devel-
opment of a variety of cancers, including colorectal cancer, is
an apparent genome-wide loss of DNA methylation (Goelz
et al., 1985). A model explaining this hypomethylation includes
that DNA methyltransferases fail to maintain normal patterns in
highly proliferative cells. Consistent with this possibility, Dnmt1
hypomorph mice show genomic instability and develop T cell
lymphomas (Gaudet et al., 2003). Also, suppression of Dnmt1
accelerates loss of heterozygosity of Nf1 in Nf1+/– p53+/– (NPcis)
mice (Eden et al., 2003). These studies argue strongly that
Dnmt1-mediated loss of methylation results in chromosomal
instability and oncogenesis. Paradoxically, however, there are
no reports of DNMT mutation or loss in tumor development.
In addition, loss or pharmacologic inhibition of DNMT1 appears
to be protective in some circumstances. Notably, adenoma
formation after loss of APC is reduced upon pharmacologic or
genetic suppression of DNMT1 (Laird et al., 1995; Eads et al.,
2002). This suggests additional regulatory mechanisms linking
loss of APC with changes in DNA methylation.
Here, we utilize zebrafish in an effort to understand the rela-
tionship between APC-dependent aberrant cell fating and a
recently described DNA demethylase system (Rai et al., 2008).
We show that homozygous loss of APC causes robust upregula-
tion of the components of the demethylase and that this impairs
the proper differentiation of intestinal cells. Mechanistically,
upregulation of the demethylase results from an absence of
retinoic acid, a factor that normally suppresses the expression
of Cebpb and Pou5f1 (previously known as Oct4), which are
direct activators of demethylase components. Genome-wide
methylation analyses using methylated DNA immunoprecipita-
tion (MeDIP) identified a panel of key intestinal cell fating genes
showing hypomethylation in apc homozygous mutant embryos,
a hypomethylation that depended upon demethylase compo-
nents. Parallel experiments with tissues taken from human
subjects showed the demethylation of these same key develop-
mental genes in human colon adenomas. Further, we demon-
strate the direct repression of the retinol dehydrogenase (RDH)
gene after APC mutation by multiple factors including LEF1,
Groucho2/TLE3, LSD1, CoREST, and CtBP1. These findings
support interplay between APC, retinoic acid, and DNA deme-
thylase components in regulating intestinal cell fating and
suggest misregulation of this interplay as an early event in colon
adenoma development after loss of APC.
RESULTS
Loss of APC Upregulates Demethylase Components
and Correlates with Demethylation of Key Target Genes
Recently, we proposed a mechanism for active DNA demethyla-
tion in zebrafish that involves the cooperative actions of proteins
from the cytidine deaminase family (activation-induced deami-
nase [Aid] and Apobec2), the G:Tmismatch-specific glycosylase
family (MBD4), and a DNA repair protein family (Gadd45) (Rai
et al., 2008). We have also observed a partially redundant role
in demethylation for theMbd4 paralog Tdg (thymine glycosylase,
data not shown), and we therefore include Tdg in our analyses.
Given the potential of DNA hypomethylation as an early event
after loss of APC, we examined the demethylase components
in zebrafish embryos harboring homozygous apc mutations
(apcmcr) that result in a truncated protein similar to those
observed in human tumors (Hurlstone et al., 2003). Remarkably,
whole-mount in situ hybridization revealed the robust upregula-
tion of components of the DNA demethylase system, includ-
ing aid, apobec2a, apobec2b, mbd4, gadd45a, gadd45alike,
gadd45b, and gadd45g and slight upregulation of tdg (Figures
1A–1C and Table S1 available online) at 72 hours postfertilization
(hpf). We observed no differences in expression of these genes
between apc mutants and wild-type embryos prior to 48 hpf
(Figure S1A and data not shown). In addition, homozygous apc
mutant embryos show slightly reduced dnmt1mRNA expression
(Figure 1D and Figures S1B–S1D). By comparison, dnmt4 and
dnmt8 appeared to be increased, whereas expression of other
dnmts did not change (Figure S1B).
Although demethylase components were upregulated in
apc mutant zebrafish embryos, we did not observe significant
changes in bulk DNA methylation (data not shown), which
largely monitors repetitive heterochromatin and transposons.
To detect genome-wide changes in DNA methylation at pro-
moters, we applied methylated DNA immunoprecipitation
(MeDIP) (Weber et al., 2007), which uses an antibody directedagainst 5-methyl-cytosine (5meC), followed by hybridization to
Agilent 244K oligonucleotide arrays that tile the majority of
zebrafish gene promoters (9 to +2 kb). Analysis of DNA taken
from whole embryos uncovered hypomethylation on a number
of interesting genes that have been implicated in intestinal fating
and development of colorectal cancer, including aldh1a2,
hoxa13a, evx1, pitx2, cyclind1, hoxd13a, junbl, frizzled8a, cdx4,
sox9b, cyclinb2, and sox4 (a complete list can be found in
Table S2). Verification of methylation status for a subset was
conducted by qPCR of MeDIP samples (Figure 1E) or bisulfite
sequencing (Figure S1E). To test whether the demethylation of
these promoters resulted from the upregulation of the demethy-
lase, we knocked down the demethylase components with
morpholino antisense oligonucleotides (hereafter referred to as
morpholinos) developed and validated in our previous studies
(Rai et al., 2008). After injection, we noted the reversal of hypo-
methylation for many genes tested (Figure 1E). Interestingly,
overexpression of dnmt1 (via mRNA injection at the one-cell
stage; protein abundance data can be found in Figure S1C)
largely failed to restore promoter methylation (Figure 1E).
Next, we examined the conservation of the above findings
in human colon adenomas obtained from FAP patients that
harbor germline APC mutations. Consistent with zebrafish
embryos, AID, MBD4, and GADD45a were significantly upregu-
lated in at least six out of 11 colon adenoma samples that
harbor germline APC mutations (Figure S1F). Genome-wide
changes in promoter DNA methylation in adenoma samples
were assessed from two different FAP patients (compared to
normal-appearing colonic tissue) with MeDIP, which revealed
significant overlap with promoters affected in apc mutant
zebrafish (a complete gene list can be found in Table S3).
A subset of these regions were tested and verified by qPCR
from MeDIP performed in FAP adenoma tissue samples from
ten different patients. The promoter regions of CYCLINB2,
HOXD13, JUN, PITX2, SOX4, and SOX17 showed demethyla-
tion (Figure 1F). PITX2 promoter hypomethylation was verified
by bisulfite sequencing in adenomas from five different patients
(Figure S1G).
Regulation of the Demethylation System
by Retinoic Acid
Previous studies indicate that APC controls both Wnt signaling
and retinoic acid biosynthesis (Phelps et al., 2009a). To deter-
mine whether aberrant demethylase expression resulted from
misregulated Wnt signaling or loss of RA production in apc
mutant zebrafish, we treated embryos with either all-trans reti-
noic acid (ATRA) or knocked-down levels of b-catenin by block-
ing Cox-2 activity with the pharmacological inhibitor (NS-398)
(Eisinger et al., 2007) (Figure S2A). Notably, treatment of apc
mutants with ATRA reduced the expression of aid, gadd45a,
and mbd4, whereas treatment with NS-398 had little effect
(Figures 2A and 2B and Table S4). However, RA treatment did
not restore dnmt1 expression (Figure S1D). Importantly, three
additional models of RA deficiency support a role for RA in down-
regulating the demethylase: rdh1l morphants (Nadauld et al.,
2005), nlsmutants (Begemann et al., 2001) and DEAB- [4-(dieth-
ylamino) benzaldehyde; an inhibitor of aldehyde dehydroge-
nases (Russo et al., 1988)] treated wild-type embryos all showedCell 142, 930–942, September 17, 2010 ª2010 Elsevier Inc. 931
Figure 1. Upregulation of DNA Demethylase Components, and Hypomethylated Genes in apc Mutant Embryos and FAP Adenomas
(A–D) Whole-mount in situ staining for aid (A), apobec2a (A), apobec2b (A),mbd4 (B), tdg (B), gadd45a (C), gadd45alike (C), gadd45b (C), gadd45g (C), and dnmt1
(D) in apc mutants (apcmcr) and siblings (apcwt) zebrafish embryos at 72 hpf.
(E) MeDIP-qPCR for genes shown (selected from genome-wideMeDIP-ChIPmicroarray analysis) in apcmcr and apcwt (72 hpf) that are either uninjected or injected
with aaaMo (combination of aid, apobec2a, and apobec2bmorpholinos; 0.5 ng each) ormbd4 and tdgmorpholinos together (1 ng each) or V5-Dnmt1 expressing
plasmid (1 pg, an amount that rescues Dnmt1 morphants with 97% knockdown of Dnmt1 levels). Dnmt1 protein levels are in Figure S1C.
(F) MeDIP-qPCR for genes shown (selected from genome-wide MeDIP-ChIP microarray analysis) in human adenomas (A) and matching uninvolved tissues (U)
from FAP patients. P1-P10 refers to ten different patients.
In both (E) and (F), the y axis shows values for each promoter region normalized to a negative control region lacking CpGs and then normalized to the values from
wild-type or uninvolved, valued at 1.
Error bars indicate ± standard deviation (SD). See also Figure S1.increased expression of the demethylase genes (Figure 2C).
Moreover, restroration of RA levels by CtBP1 knockdown in
apcmcr embryos led to demethylase downregulation (Fig-
ure 2A). Finally, RA treatment led to repression of AID, MBD4,
and GADD45a levels in human colon cancer cell lines (Fig-
ure S2B). Similar to our results after morpholino knockdown of932 Cell 142, 930–942, September 17, 2010 ª2010 Elsevier Inc.demethylase components, treatment of apc mutant embryos
with RA reversed the loss of DNA methylation observed on
the panel of genes implicated in intestinal differentiation and
proliferation (Figure 2D). Taken together, our data provide
multiple lines of evidence for robust downregulation of demethy-
lase components by retinoic acid.
Figure 2. APC Negatively Regulates Demethylase Expression via Retinoic Acid
(A) Whole-mount in situ staining for aid, gadd45a, andmbd4 in apcmcr and apcwt embryos treated with DMSO, all-trans retinoic acid (ATRA, 1 mM), or Cox-2 inhib-
itor NS-398 (10 mM) or injected with control morpholino or ctbp1 morpholino (2 ng). b-catenin knockdown efficiency with NS-398 treatment is depicted in
Figure S2A.
(B and C) Quantitative RT-PCR for aid,mbd4, and gadd45a in apcmcr and apcwt embryos treated with DMSO or ATRA (B) or in different RA deficiency models in
zebrafish, as shown in (C). Expression of genes are first normalized to 28S and then to the control embryo mRNA/28S ratio, valued as 1.
(D) MeDIP-qPCR for genes shown (as in Figure 1E) in apc mutants (72 hpf) that are either untreated or treated with ATRA.
Error bars indicate ± SD. See also Figure S2.Cebpb and pou5f1 Mediate Regulation of the
Demethylase Downstream of Retinoic Acid
We have shown previously that, although apc mutant embryos
develop primordial intestines expressing key patterning markers
such as such as gata6, foxa3, gata5, hnf1b, and hnf4a (Fig-
ure S3A), these intestinal cells fail to differentiate. Differentiation
failure results from loss of retinol dehydrogenase (RDH) expres-
sion which catalyzes the conversion of dietary retinol into retinal-
dehyde (Jette et al., 2004; Nadauld et al., 2004; Nadauld et al.,
2005). To better understand the status of RA biosynthesis after
apc mutation, we also examined the expression of aldh1a2
(also known as raldh2), which further coverts retinaldehyde into
retinoic acid. (We note that zebrafish lack aldh1a1.) ALDH1 is
a commonly used marker of normal and cancer stem cells,
including those derived from human colon and colon carcinomas
(Huang et al., 2009). Whole-mount in situ hybridization revealed
upregulation of aldh1a2 in apc mutants beginning at 36 hpf that
remained elevated through 72 hpf (Figure 3A and Figures S3Band S3C). This was paralleled by increased aldh1a2 protein
levels (Figure S3D). The upregulation of aldh1a2 in apcmcr
embryos combined with an absence of retinol dehydrogenases
(rdh1 and rdh1l) suggested poising of the intestinal progenitor
cells for retinoic acid biosynthesis upon production of the
required substrate. Indeed, treatment of apcmcr embryos with
exogenous retinaldehyde (RAL) partially restored intestinal
differentiation marked by fabp2 expression (Mudumana et al.,
2004) (Figure 3B), a result we also observed in rdh1l morphant
embryos (Figure 3C). Consistent with studies indicating that
aldh1a2 expression can be repressed by RA (Dobbs-McAuliffe
et al., 2004) (Niederreither et al., 1997), treatment of apcmutant,
rdh1l morphant or nls mutant embryos with RA decreased the
expression of aldh1a2 (Figures S3C, S3E, and S3F).
Since RA can directly repress transcription of pou5f1 in the
zebrafish by binding to a RARE in the pou5f1 promoter (Parvin
et al., 2008) and since a related POU family transcription factor
activates expression of aldh1a1 (Guimond et al., 2002), weCell 142, 930–942, September 17, 2010 ª2010 Elsevier Inc. 933
Figure 3. Pou5f1 and Cebpb Directly Regulate aid, mbd4, and gadd45a Expression in apcmcr Embryos
(A) Whole-mount in situ staining for aldh1a2 in apcmcr and apcwt at 72 hpf.
(B and C) Whole-mount in situ staining for fabp2 in apcmcr and apcwt embryos (B) or in control morphant and rdh1lmorphant embryos (C) (at 72 hpf) treated with
vehicle or RAL (2 mM).
(D) RT-PCR for Pou5f1 (Oct4) andCebpb in apcmcr and apcwt treated with DMSO or ATRA (1 mM). The y axis shows fold induction normalized to 28S andwild-type
DMSO-treated sample.
(E and F) Whole-mount in situ staining for aid, gadd45a, and mbd4 in apcmcr and apcwt injected with control, Pou2f1a, pou5f1, or cebpb Mo (E) or in wild-type
embryos injected with control, Pou2f1, pou5f1, or cebpb expression plasmid (F).
(G) Graph showing fold enrichment near the aid or gadd45a TSS (containing overlapping Oct and Cebp binding sites) for Cebpb and Pou5f1 in embryos injected
with V5-Cebpb- (along with Pou5f1 Mo, 80 pg), V5-Pou5f1-, or FLAG-Pou2f1-expressing plasmids. ChIP was performed with antibodies against the tags.
Normalization control primers are located 3 kb upstream (region without Cebpb sites) of the TSS of the Gadd45a gene.
Error bars indicate ± SD. See also Figure S3.examined the expression of pou5f1 in apcmcr embryos and found
it elevated (Figure 3D). Furthermore, treatment of apcmcr
embryos with RA reduced the expression of pou5f1 (Fig-
ure 3D). Cebpb is another transcription factor upregulated in
apc mutants and downregulated by RA treatment (Figure 3D)
(Eisinger et al., 2006). Since components of the demethylase
complex contain OCT and CEBP sites in their promoter, we sup-934 Cell 142, 930–942, September 17, 2010 ª2010 Elsevier Inc.pressed Cebpb and Pou5f1 levels in apcmutants by injection of
morpholinos and observed reduced expression of the demethy-
lase to an extent similar to that elicited by treatment with RA
(Figure 3E and Table S4). As a control, we also knocked down
Pou2f1a (aka Oct1), Smad4, and Tcf3a/3b and saw no effect
(Figure 3E, Table S4, and data not shown). To test whether
Pou5f1 and Cebpb were sufficient to upregulate these genes,
we overexpressed each and observed robust upregulation of
all demethylase components in multiple tissues (Figure 3F and
Figures S3G and S3H). Knockdown of pou5f1 also caused a
significant reduction in the aldh1a2 expression in apc mutants
as measured by whole-mount in situ and quantitative RT-PCR
(Figures S3I and S3J).
Notably, gadd45a and aid promoters contain adjacent and
partially overlapping OCT and CEBP recognition sequences at
+400 and 1300 position from their respective transcription
start sites (TSSs). To assess binding, we performed chromatin
immunoprecipitation (ChIP) after the expression of tagged deriv-
atives in 56 hpf embryos. Here, Pou5f1 enrichment was readily
detected on both aid and gadd45a promoters when overex-
pressed (Figure 3G). Significant Cebpb enrichment was detected
when Cebpb was overexpressed along with a small amount of
pou5f1 morpholino (Figure 3G); however, without pou5f1 mor-
pholino, Cebpb enrichment was 2-fold. It is possible that
Pou5f1 sterically hinders binding of exogenous Cebpb. These
data suggest that both Pou5f1 and Cebpb, whose levels are
regulated by retinoic acid, are direct positive regulators of deme-
thylase genes.
The Demethylase System Helps Maintain Intestinal
Epithelial Cells in an Undifferentiated State after Loss
of Apc
As shown above, apc mutant embryos expressed high levels
of aldh1a2, a marker of colon crypt progenitor cells, (Figures
3A and 4A and Table S5) (Huang et al., 2009). Further, the
aldh1a2 promoter was hypomethylated in apc mutant embryos
(Figure 1E), and this hypomethylation relied on demethylase
components (Figure 1E). In examining intestine-specific effects,
we noted that cross-sections of whole-mount in situ-stained
embryos revealed clear upregulation of aid (52 hpf) and mbd4
(72 hpf) within the intestine of apc mutants (Figure 4B). Further,
we generated an apc mutant line carrying gut-specific GFP
driven by the foxa3 promoter and used these to sort and enrich
gut cells from whole embryos. Sorting of GFP-positive cells
resulted in approximately 11-fold enrichment based on RT-
PCR analysis of fabp2 expression in parallel wild-type embryos
(Figures S4A and S4B). Analysis of DNA isolated from GFP-
selected cells demonstrated specific demethylation of aldh1a2,
hoxa13a, hoxd13a, cyclind1, and pitx2 in apcmutants compared
to siblings (Figure 4C). Given these intestine-specific effects, we
tested whether the demethylase components were required for
maintaining the undifferentiated progenitor population in apc
mutants. Notably, knockdown of demethylase components,
but not of Pou2f1a, Tcf3a/3b, or Smad4 (as controls), in apc
mutant embryos reduced expression of aldh1a2 as determined
both by whole-mount in situ hybridization and RT-PCR (Fig-
ure 4A, Figure S4C, Table S5, and data not shown), an effect
that was paralleled by increased intestinal differentiation
assessed by fabp2 expression (Figure 4A, Figure S4C, and
Table S5). Interestingly, analysis of DLD1 and HT29 colon cancer
cell lines showed increased expression of AID, MBD4, and
GADD45a in ALDH-positive cells (colon stem cells) in compar-
ison to ALDH negative fractions (Figure S4D).
We observed a clear affect on the expression pattern of
hoxa13a; wild-type embryos restrict hoxa13a expression to thedistal tip of the gut, whereas expression is observed throughout
the gut in apc mutants. Strikingly, knockdown of demethylase
components restores proper spatial expression of hoxa13a in
apc mutant embryos (Figure 4A and Table S5). Furthermore,
hoxa13a was hypomethylated in apc mutant guts in a demethy-
lase-dependentmanner (Figures 1E and4C). Finally, overexpres-
sion of dnmt1 did not affect expression of these markers (Fig-
ure 4A), focusing the causal affect on the upregulation of the
demethylase rather than the possible downregulation of dnmt1.
The above studies in embryos suggested a model wherein
retinoic acid-mediated suppression of the DNA demethylase
system is essential for intestinal differentiation. Next, we exam-
ined the impact of retinoic acid deficiency in the adult zebrafish
intestine via treatment for 7 days with DEAB to inhibit retinoic
acid biosynthesis. This treatment caused a profound conversion
of intestinal cells to a proliferative phenotype as assessed by
PCNA staining and incorporation of BrdU (Figure 4D). Treatment
of adults with both DEAB and ATRA restored normal proliferation
and confirmed the specificity of the DEAB treatment (Figure 4D).
Consistent with our findings in embryos, intestines from DEAB-
treated adults showed increased expression of aid, gadd45a,
mbd4, aldh1a2, and cyclinD1, with fabp2 levels coincidently
reduced (Figure 4E and Figure S4E). Consistent with these
changes in expression, intestinal cells from the DEAB-treated
adults showed demethylation of aldh1a2, hoxa13a, hoxd13a,
cyclind1, and pitx2 (Figure 4F).
The Demethylase Governs Cell Proliferation in the Brain
after Apc Loss
The impact of the demethylase system extends beyond intes-
tinal differentiation, as clear effects on brain proliferation were
observed in apc mutants. First, we observed high levels (by
in situ staining) of pcna, cyclind1, and pitx2 (which activates
cyclind1) within brain of apc mutants, which was greatly attenu-
ated by knockdown of demethylase components but not through
ectopic dnmt1 expression (Figure S4F and Table S5). Further-
more, increased pcna and cyclind1 expression depended on
Pitx2 (Figure S4F). As with the gut, primordial brain markers
appeared to be normal in apcmcr embryos and ruled out gross
patterning defects in accounting for the observed phenotypes
(Figures S4G and S4H).
Lef1 andGroucho2Directly Repress rdh1l and Suppress
Intestinal Differentiation
Next, we sought to determine the mechanism of RDH repression
upon apc mutation to better understand the regulation of RA
production. The RDH promoter in both humans and zebrafish
contains numerous TCF/LEF binding sites, and apcmcr embryos
expressed aberrantly high levels of lef1 and its coregulator, grou-
cho2, but not of tcf4 or groucho3 (Figure 5A and Figure S5A).
Remarkably, knockdown of Lef1 in apcmcr embryos improved
many of the overt morphological defects present in apcmcr
embryos, including intestinal and pancreatic differentiation,
but not eye-differentiation defects (Figure 5B, Figures S5B–
S5F, and Table S6). Knockdown of either Lef1 or Groucho2
(Figure S5G) was accompanied by the induction of rdh1l expres-
sion within the intestine (Figure 5B and Table S6). Importantly,
Lef1 directly regulates rdh1l expression, as ChIP experimentsCell 142, 930–942, September 17, 2010 ª2010 Elsevier Inc. 935
Figure 4. Demethylase Activity Is Required to Maintain Progenitor Cell Populations in apc Mutants
(A) Whole-mount in situ staining for aldh1a2, fabp2, and hoxa13a in apcmcr and apcwt embryos injected with control Mo, aaaMo, combinedmbd4 and tdgMo, or
overexpression of dnmt1 as in Figure 1.
(B) Cross-sections of the intestines of apcmcr and apcwt embryos whole-mount in situ stained with aid (52 hpf) ormbd4 (72 hpf). Asterisks show pronephric ducts,
and arrows point to the intestine. N, notochord; SC, spinal cord.
(C) MeDIP-qPCR for genes shown in the GFP-positive cells from gutGFP;apcmcr and gutGFP;apcwt embryos (72 hpf). FACS parameters and efficiency are shown
in Figures S4A and S4B.
(D–F) Immunostaining (D), RT-PCR (E), andMe-DIP PCR (F) for the indicated genes in the intestines from adult wild-type zebrafish treated with DMSO or DEAB for
7 days. In (E), RT-PCR was performed on epithelial cells isolated from the intestinal crypts.
Error bars indicate ± SD. See also Figure S4.revealed a 7.4-fold enrichment of Lef1 on the rdh1l promoter
(second and the third Lef1 binding sites upstream of the TSS,
Figure 5C) in apcmcr embryos compared to their wild-type
siblings (Figure 5D). Coinjection of both lef1 and groucho2936 Cell 142, 930–942, September 17, 2010 ª2010 Elsevier Inc.mRNA, but not either alone, reduced expression of fabp2 in
the intestine of 80 hpf wild-type zebrafish embryos (Figure 5E
and Table S6). The expression of gata6, a marker of primordial
gut, was unaffected by injection of lef1 and groucho2 mRNA,
Figure 5. Lef1 and Groucho2 Suppress
rdh1l in apcmcr Zebrafish
(A) Whole-mount in situ staining for lef1, groucho2,
tcf4, or groucho3 in apcwt and apcmcr embryos at
72 hpf. Red arrow points to the intestine.
(B) Whole-mount in situ staining for fabp2,
trypsin, rdh1l, and irbp in apcmcr/control Mo,
apcmcr /lef1 Mo, and apcmcr /groucho2 Mo
embryos at 72 hpf. Groucho2 mo efficiency is in
Figure S5G.
(C and D) ChIP for Lef1 on rdh1l promoter in apcwt
and apcmcr embryos.
(C) Schematic showing the Lef1 sites on the
rdh1l promoter and location of the primer set
P1 (containing Lef1 sites) and P2 (without Lef1
sites).
(D) Graph showing fold enrichment of Lef1
occupancy at P1/P2 on rdh1l promoter in apcmcr
embryos compared to apcwt at 72 hpf. Lef1 values
were normalized to ones obtained with a nonspe-
cific antibody and then expressed as fold enrich-
ment compared to apcwt. Error bars indicate ± SD.
(E) Whole-mount in situ staining for fabp2 and
gata6 in 72 hpf embryos injected with full-length
lef1 or dominant negative (deficient in b-catenin
binding) lef1mRNA alone or with groucho2mRNA.
See also Figure S5.thereby eliminating the possibility that the intestine failed to
develop (Figure 5E).
Retinoic acid production in APC mutant human cells is b-cat-
enin independent (Nadauld et al., 2006, Phelps et al., 2009a,
2009b), and we reinforce this by showing that reduction in
b-catenin levels by morpholino knockdown or pharmacological
inhibition of Cox-2 (an upstream regulator of b-catenin) did not
change levels of rdh1l or fabp2 in apcmcr zebrafish embryos
(Figures S5H–S5J). Surprisingly, and consistent with data pre-
sented here, Lef1 levels remained unchanged upon b-catenin
knockdown but were rescued upon reintroduction of APC
(Figures S5J–S5K). Human LEF1 physically interacts with Grou-
cho/TLE family members in the absence of WNT signaling.
Notably, human LEF1 and TLE3 (a homolog of Groucho2)
showed robust interaction by coimmunoprecipitation (Fig-
ure 6A) and, similarly, zebrafish Lef1 and Groucho2 interacted
(data not shown) in SW-480 cells, which harbor an APCmutation.
A role for LEF1 and TLE3 overexpression may extend to human
samples, as they were each significantly upregulated in 50%–
60% of the ten adenoma samples tested (Figures S6A and
S6B). Next, we analyzed roles of LEF1 and Groucho2/TLE3 in
repressing retinol dehydrogenase expression in three colonCell 142, 930–942, Secancer cell lines harboring APC muta-
tions: DLD1, HT29, and SW480. LEF1
and TLE3 were knocked down with short
interfering RNAs (siRNAs), which signifi-
cantly reduced their respective expres-
sion (Figures S6C and S6D) and restored
DHRS9 (previously known as RDHL)
expression in all three cell lines (Fig-
ure 6B). These data strongly support rolesof LEF1 and TLE3 together in repressing RDH expression in
zebrafish and humans.
LEF1/TLE3 Represses Retinol Dehydrogenase through
Recruitment of the CtBP1/LSD1 Corepressor Complex
CtBP1 appears to suppress retinol dehydrogenase (RDH)
expression in colon cancer cell lines and in apcmcr zebrafish
(Nadauld et al., 2006). It has been shown to exist in a multiprotein
repressor complex that includes the histone demethylase LSD1
and the scaffold CoREST (Shi et al., 2003). Interestingly, immu-
noprecipitation of TLE3 from SW480 cells efficiently coprecipi-
tated CtBP1 (Figure 6C) and LSD1 (Figure 6D). Furthermore,
LEF1 coprecipitated LSD1, suggesting that CtBP1/LSD1 com-
plex can interact with both LEF1 and TLE3 (Figure 6E). Next,
we tested whether these interacting proteins can occupy the
DHRS9 promoter. To test this, we performed ChIP of CtBP1
and LSD1 on the DHRS9 promoter in SW480 cells, which
revealed significant enrichment of CtBP1 and LSD1 on the
DHRS9 promoter region containing LEF1 sites (Figure 6F).
Furthermore, CtBP1 and LSD1 occupancy of the DHRS9 pro-
moter was reduced in cell lines treated with LEF1 siRNA, sug-
gesting that LEF1 helps in recruitment of CtBP1 complex toptember 17, 2010 ª2010 Elsevier Inc. 937
Figure 6. CtBP1 and LSD1 Physically
Interact with LEF1/Groucho2/TLE3 and
Repress RDHL/DHRS9 Expression
(A and C–E) Western blot showing coimmunopre-
cipitation between LEF1 and TLE3 (A), CtBP1 and
TLE3 (C), LSD1 and TLE3 (D), and LEF1 and LSD1
(E) in SW480 cells. Antibodies used for IP are
shown on top, and antibodies used for immuno-
blot are shown adjacent to the blot.
(B and H) Quantitative PCR measuring DHRS9
(RDHL) expression in DLD1, SW480, and HT29
cells that were transfected with either a Scrambled
(SCR) siRNA or specific siRNAs against LEF1 or
TLE3 (B) or siRNAs against LSD1 or CoREST (H)
or treated with pargyline (3 mM) (H). siRNA knock-
down efficiency is shown in Figures S6C–S6F. The
y axis values represent the fold change in DHRS9
expression. Normalization for DHRS9 absolute
values was done first to 18S rRNA values and
then to DHRS9/18S ratio from Scr siRNA.
(F and G) ChIP of CtBP1 and LSD1 in untreated (F)
or SCR or LEF1 siRNA-treated (G) SW480 cells on
the DHRS9 promoter.
(F) PCR-amplified product was run on agarose gel
that shows enrichment on a region on DHRS9
promoter that contains LEF1 sites (P1) compared
to a region devoid of LEF1 sites (P2).
(G) Quantitative PCR showing enrichment of
CtBP1 and LSD1. The y axis shows fold enrich-
ment on P1 compared to P2.
Error bars indicate ± SD. See also Figure S6.DHRS9 promoter (Figure 6G). Also, knockdown of LSD1 by
siRNA was sufficient to restore DHRS9 levels in DLD1, HT29,
and SW480 cells (Figure 6H and Figure S6E). Moreover, inhibi-
tion of LSD1 enzymatic activity by treatment with pargyline
(Shi et al., 2004) also upregulated DHRS9 expression in all
three cell lines (Figure 6H). Finally, knockdown of CoREST also
restored DHRS9 expression in the same three cell lines (Fig-
ure 6H and Figure S6F). Taken together, these data suggest
that a LEF1/TLE3 module binds to the retinol dehyrogenase
promoter and recruits the CtBP1/LSD1/CoREST complex for
repression.
LSD1 and CoREST Are Upregulated in APC Mutant
Tissues and Repress DHRS9
CtBP1 protein levels are elevated in APC mutant cells (Nadauld
et al., 2006), as they lack APC- and proteasome-mediated
CtBP1 destruction.We tested LSD1 protein levels in FAP polyps.
Immunostaining on cross-sections of FAP colonic adenomas938 Cell 142, 930–942, September 17, 2010 ª2010 Elsevier Inc.showed upregulation of both LSD1 and
CtBP1 compared to matched normal
mucosa samples (Figure S6G). Western
blot further confirmed upregulation of
LSD1 protein in FAP polyps compared
to matched normal tissue (Figure S6H).
Here, unlike CtBP1, and similar to LEF1
and TLE3, LSD1 transcript levels were
upregulated in multiple adenoma tissues
by RT-PCR analysis (Figure S6I).Next, we tested whether LSD1 and CoREST function in intes-
tinal differentiation and retinol dehydrogenase regulation using
zebrafish. Immunoblot analysis revealed Lsd1 and Ctbp1 protein
upregulation in apcmcr zebrafish embryos (Figure S7A). Similar to
adenomas, the transcript levels of Lsd1 and Corest are also
upregulated in apcmcr zebrafish embryos at 80 hpf, as examined
by whole-mount in situ staining (Figure 7A) and verified by RT-
PCR (Figure S5A). Importantly, knockdown of Lsd1 and Corest
rescued the expression of intestinal rdh1l in apcmcr embryos (Fig-
ure 7B and Figures S7B and S7C). Furthermore, rescue of rdh1l
expression was accompanied by restoration of intestinal dif-
ferentiation (fabp2), but not retinal differentiation (irbp) (Fig-
ure 7C). Treatment of apcmcr zebrafish embryos with pargyline
also rescuedexpressionof rdh1l (Figure7B)and fabp2 (Figure7C),
suggesting that the catalytic activity of Lsd1 is essential for this
regulation in zebrafish. These data suggest that Lsd1 and Corest
are required to maintain the repression of rdh1l and the undiffer-
entiated status of the intestines of apcmcr zebrafish embryos.
Figure 7. Lsd1 Represses rdh1l Expression
and Intestinal Differentiation, and a Model
for Retinoic Acid Regulation of DNAMethyl-
ation Dynamics
(A) Whole-mount in situ staining for lsd1 and corest
in the intestine (arrows) of apcmcr and apcwt
embryos (72 hpf).
(B) Fold change in rdh1l expression compared to
28S levels in apcwt and apcmcr embryos injected
with control/lsd1/corestMo or treated with pargy-
line (to inhibit Lsd1 activity). Error bars indicate ±
SD. Lsd1 and Corest morpholino knockdown effi-
ciency is shown in Figures S7A and S7B.
(C) Whole-mount in situ staining for fabp2 and
irbp in apcmcr and apcwt embryos injected with
control/lsd1/corest Mo or treated with pargyline
(3 mM).
(D and E) Model of APC regulation of intestinal
fating via retinoic acid and demethylase. APC
promotes RA production by directly negatively
regulating CtBP1 levels in a proteasome-depen-
dent fashion. APC also inhibits the transcription
of LSD1, CoREST, LEF1, and TLE3. LEF1 binds
to the RDH promoter and recruits TLE3 (Grou-
cho2)/CtBP1/LSD1 repressors, which silence
RDH expression. Retinoic acid negatively regu-
lates demethylase components by inhibiting
Pou5f1 and Cebpb. Furthermore, regulation of
demethylase components by APC is independent
of b-catenin. Demethylase promotes the demethy-
lation of key fate regulators (like aldh1a2, hoxa13a,
evx1) and proliferative genes (like cyclind1 and
pitx2). Fate regulators like aldh1a2 possibly help
in maintaining a progenitor cell population.
See also Figure S7.DISCUSSION
Genomic hypomethylation was proposed by Holliday as an
oncogenic mechanism nearly 25 years ago (Holliday and
Jeggo, 1985). Since then, many studies have focused on DNA
methyltransferases and the paradoxical hypermethylation of
tumor suppressor genes that occurs in the background of
genome-wide hypomethylation. Mechanisms explaining the
underlying hypomethylation, its contribution to tumor initiation
and progression, and its relationship to genetic events are
largely unknown. Here, we present a model linking APC
loss—a key genetic determinant of colon adenoma develop-
ment—with the misregulation of DNA methylation dynamics
through activation of a DNA demethylase system. This dynamic
regulation appears to be critical to the proper fating of intestinal
cells in zebrafish and targets key regulators of cell maintenance
and differentiation. Mechanistically, loss of APC results inCell 142, 930–942, Sesuppression of retinoic acid biosynthesis
due to repression of RDH by aberrant
upregulation of a transcriptional complex
including LEF1, Groucho2/TLE3, CtBP1,
LSD1, and Corest. Downstream of reti-
noic acid loss, the transcriptional regula-
tors Pou5f1 and Cebpb appear to berequired for activation of the demethylase components
(Figure 7D).
Recent studies have confirmed the involvement of AID in DNA
demethylation during reprogramming of human cells (Bhutani
et al., 2010) and in the erasure of DNA methylation from mouse
primordial germ cells (Popp et al., 2010). Our data offer a new
mechanistic explanation for previous studies implicating DNA
hypomethylation in cancer development (Goelz et al., 1985).
Other models have considered the possibility that genome-
wide demethylation during tumorigenesis results from the
inability of DNA methyltransferases to maintain normal DNA
methylation patterns in highly proliferative cells. Interestingly,
we observed a loss of dnmt1 in parallel with upregulation of
the demethylase system in apc mutant zebrafish embryos.
However, unlike knockdown of the demethylase components,
injection of dnmt1 into apc mutants failed to restore intestinal
differentiation and methylation on specific genes. This findingptember 17, 2010 ª2010 Elsevier Inc. 939
suggests a major role for the misregulation of the demethylase,
rather than Dnmt1 loss, in maintaining the progenitor-like state
of intestinal cell present in apc mutants. Consistent with this
model, knockout of Apobec-1, a mammalian 5meC deaminase
highly related to AID (Morgan et al., 2004), reduced adenoma
formation in the ApcMin mouse model (Blanc et al., 2007).
Our work also provides insight into an apparent contradiction
brought about by previous studies indicating that genetic loss
or pharmacologic inhibition of DNMT1 appears protective in
some circumstances (Eads et al., 2002; Laird et al., 1995). It is
important to note that the demethylase system works through
a process that first involves deamination of 5meC to thymine
and that it may therefore enhance C to T transitions. It is possible
that loss of methylation due to DNMT1 inhibition lowers the yield
of deamination products (5meC/T transitions) by removing the
substrate, 5meC. This could in turn slow adenoma progression
by limiting this mode of mutation. Interestingly, Laird et al. spec-
ulated reduced mutation rates in the ApcMin mice treated with
5-Aza-cytidine as this treatment effectively prevented adenoma
initiation but failed to affect established polyps (Laird et al.,
1995). Similarly, knockout of MBD4 increases intestinal tumori-
genesis in parallel with increased rates of C to T transitions (Millar
et al., 2002).
Although the transcriptional effects of retinoic acid in control-
ling cell patterning, fate, and differentiation arewell documented,
the regulation of RA production as a determinant of cell fate
decisions is less well understood. Production of retinoic acid
requires converting dietary retinol (vitamin A) into retinoic acid,
a process that occurs via two enzymatic steps (Duester, 2000):
the conversion of retinol into retinal by alcohol dehydrogenases
(ADHs) and short-chain dehydrogenases (SDRs), followed by the
conversion of retinal into retinoic acid via aldehyde dehydroge-
nases (ALDHs) (Duester, 2000). Studies in mice and chickens
indicated that RALDHs, rather than RDHs, represent the primary
point for regulating tissue-specific production of retinoic acid
(Duester et al., 2003). Recent studies in zebrafish, however,
have demonstrated that Rdh1 and Rdh1l are essential for intes-
tinal differentiation and the development of the pectoral fin, jaw,
eye, and exocrine pancreas (Nadauld et al., 2004; Nadauld et al.,
2005). Our findings here provide a model suggesting a dynamic
inverse relationship between RDHs and ALDHs in regulating
RA production in intestinal cells. In this model, high levels of
ALDH appear to poise cells for RA production upon generation
of RAL by RDH. This, in turn, initiates a program of differentiation
that relies in part on the suppression of the demethylase system
(Figure 7E).
Interestingly, we show that multiple transcriptional repressors,
namely LEF1, Groucho2/TLE3, CtBP1, LSD1, and CoREST,
work together to repress the production of retinoic acid by direct
binding to, and repression of, the rdh1 promoter. Further, the
activity of LSD1 is required for maintaining repression of the
RDH promoter in the presence of APC mutation. Consistent
with the model, knockdown of these proteins restored rdh1l
expression and intestinal differentiation to apcmutants. Further-
more, our data indicate that APC regulation of RDHs and the
demethylase system occurs independently of b-catenin, thereby
revealing a novel role for LEF1, which is known to be upregulated
in sporadic colon carcinomas (Hovanes et al., 2001) but thought940 Cell 142, 930–942, September 17, 2010 ª2010 Elsevier Inc.previously to act primarily through an interaction with b-catenin.
Consistent with this idea, human FAP adenoma tissues also
showed increased levels of all of these factors. Taken together,
these data support a model wherein mutations in APC cause
upregulation of LEF1, Groucho2/TLE3, CtBP1, LSD1, and
CoREST and that this complex serves to repress intestinal differ-
entiation by directly targeting RDHs.
Our results suggest a mechanism for a rapid and robust
changes in DNA methylation dynamics during development,
mediated by retinoic acid. We observe a marked upregulation
of demethylase components in RA-deficient embryos and a
marked downregulation of demethylase components after treat-
ment with retinoic acid. Notably, we demonstrate that retinoic
acid antagonizes two key direct activators of demethylase
components, Pou5f1 and Cebpb, leading to demethylase down-
regulation. These results raise the possibility that part of the basis
for the developmental plasticity and maintenance of progenitor
cells is the DNAmethylation dynamics provided by the demethy-
lase system. Loss of demethylase activity upon exposure to ret-
inoic acid may favor the imposition of DNA methylation patterns
at the promoters of key developmental regulators, which may
help commit cells to differentiation and help maintain that com-
mitment. Further studies will determine the potential roles for
other candidate demethylase components downstream of APC.
In summary, we have shown that DNA cytosine demethylases
are upregulated in APC mutant human and zebrafish tissue and
are responsible for demethylation of genes that are important for
maintaining a progenitor cell population in APC mutant tissues.
These findings offer a mechanistic model implicating active
DNA demethylation in contributing to cell fating defects after
loss of APC.
EXPERIMENTAL PROCEDURES
Zebrafish Care and Injections
Wild-type (Tu strain), apc heterozygous (kind gift of Anna Pavlina-Haramis and
Hans Clevers), and gutGFP adults [Tg(XlEef1a1:GFP)s854; obtained from ZIRC]
adults maintained in Z-Mods at 28C in a 14:10 hr light cycle. For all whole-
mount in situ experiments, embryos were raised in 0.003% phelthiourea
(PTU)-treated embryo water to inhibit pigment formation. Morpholinos
(Gene-tools), DNA, and RNA were injected at the one-cell stage. Sequences
are available in the Extended Experimental Procedures.
Whole-Mount In Situ Hybridization
Whole-mount in situ hybridizations were performed as described earlier
(Nadauld et al., 2004). Riboprobes for the indicated genes were made with di-
goxigenin-labeled UTPs (Roche). Genes were cloned in pCR-II-TOPO vector
(Invitrogen).
Cell Culture and Transfection
SW480, DLD1, and HT29 cells were purchased from ATCC and grown accord-
ing to the guidelines of the manufacturer. Transfection experiments were per-
formed with Lipofectamine 2000 (Invitrogen) according to the manufacturer’s
recommendations. After transfection, cells were incubated for 24 hr (DNA),
48 hr (IP) or 72 hr (siRNA) and then harvested for western blotting analysis,
immunoprecipitation, or RT-PCR.
RT-PCR
RNA from whole embryos or human adenoma tissues was isolated with Trizol
(Invitrogen). cDNA library was prepared with the Superscript III kit (Invitrogen).
RT-PCRwas performed on a Roche light cycler. Primer information is available
upon request.
Western Blotting
Protein extracts were made and western blotting was performed as described
earlier (Rai et al., 2008).
Drug Treatments
Embryos were treated with all-trans retinoic acid (1 mM) or DMSO (vehicle)
every day starting at 24 hpf for 45 min. NS-398 treatment was similar except
at 10 mM. For pargyline treatment, drug (3 mM or water control) was left in
embryo water starting at 75% epiboly, and new drug as added every day. Cells
were treated with pargyline at 3mMor all-trans retinoic acid (or DMSO) at 1 mM
each day for 2 days, and RNA was isolated.
Methylated DNA Immunoprecipitation and Array Hybridization
The methylated DNA immunoprecipitation (MeDIP) procedure was previously
described (Weber et al., 2007). In brief, Dynabeads (conjugated with sheep
anti-mouse secondary antibody, Invitrogen) were incubated with 10 mg
5MeC antibody (Eurogentec) for 2 hr, washed and then incubated with 4 mg
of sonicated DNA (300–1000 bp fragments) overnight. Immunoprecipitated
DNA was used for qPCR or amplified with whole-genome amplification
kit (Sigma Aldrich). After amplification, 2 mg amplified DNA was labeled with
Cy5, and 2 mg input DNA was labeled with Cy3 (Bio labs). Samples were
competitively hybridized to 244K oligonucleotide promoter arrays (Agilent).
Chromatin Immunoprecipitation
ChIP was performed as described earlier (Rai et al., 2008). ChIP for Cebpb and
Pou5f1 were performed in wild-type (Tu) whole embryos. V5-zfCEBPb (along
with pou5f1 morpholino, 80 pg) or V5-zfPou5f1 (both cloned in pcDNA3.1/
nV5 DEST; Invitrogen) was injected at the one-cell stage, and embryos were
collected at 48 hpf. ChIP was performed with V5 antibody (Abcam). ChIP for
Lef1 was performed with rabbit-anti-zfLef1 antibody in extracts made from
apcwt and apcmcr whole embryos collected at 72 hpf. ChIP in SW-480 cells
were performed with antibodies a-CtBP (Santa Cruz; sc-11390), a-LSD-1
(Abcam; ab-17721), and rabbit IgG (control).
Coimmunoprecipation
Constructs expressing tagged proteins were transfected in SW480 cells and
protein harvested in 13 IPH buffer 48 hr after transfection. Immunoprecipita-
tion was performed as described earlier (Rai et al., 2008) with rabbit-a-V5 anti-
body (Abcam) or a-Myc monoclonal antibody. Western blot was probed with
mouse-a-V5 (Invitrogen), mouse-a-GFP (BD Biosciences), rabbit-a-myc
(Santa Cruz), and rabbit-a-V5 (Abcam) antibodies.SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures, seven
figures, and six tables and can be found with this article online at doi:10.1016/
j.cell.2010.08.030.
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